Form 4: Elevance Health Director Ryan M. Schneider Reports Acquisition of Deferred Stock Units

Director Ryan M. Schneider reported acquiring 388 deferred stock units of Elevance Health, Inc.

Summary

• Ryan M. Schneider, a director of Elevance Health, Inc., filed a Form 4 to report changes in beneficial ownership.
• The report indicates that Schneider acquired 388 deferred stock units on May 15, 2024, under the Elevance Health, Inc. Board of Directors Compensation Program.
• These deferred stock units will be payable in Company common stock upon the earlier of (a) five years from the grant date or (b) the date Schneider ceases to be a member of the Company's board of directors, unless a later date is designated.
• Following the reported transaction, Schneider beneficially owns 5,999 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.

Future Outlook

The deferred stock units will be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Industry Context

This filing is a routine disclosure related to director compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence as it reflects a director's increased stake in the company.

Key Dates